Published in Clin Infect Dis on July 01, 2009
Clinical Decision Support Tool for Vancomycin Dosing in Children | NCT04911270
Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol (2011) 1.83
Knowledge, awareness, and attitudes regarding methicillin-resistant Staphylococcus aureus among caregivers of hospitalized children. J Pediatr (2010) 1.54
Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J (2013) 1.52
Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants. JAMA Pediatr (2015) 1.48
Panton-valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One (2009) 1.48
Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One (2012) 1.43
A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis. Cell Host Microbe (2013) 1.31
Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr (2014) 1.26
PSMs of hypervirulent Staphylococcus aureus act as intracellular toxins that kill infected osteoblasts. PLoS One (2013) 1.26
A literature review and survey of childhood pneumonia etiology studies: 2000-2010. Clin Infect Dis (2012) 1.21
Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation. Clin Ther (2010) 1.15
Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study. Pediatr Blood Cancer (2010) 1.15
Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy (2011) 1.09
Pharmacokinetics of tedizolid following oral administration: single and multiple dose, effect of food, and comparison of two solid forms of the prodrug. Pharmacotherapy (2013) 1.05
Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents. Clin Pharmacol Ther (2014) 1.03
The Regional Healthcare Ecosystem Analyst (RHEA): a simulation modeling tool to assist infectious disease control in a health system. J Am Med Inform Assoc (2013) 1.03
Spread of epidemic MRSA-ST5-IV clone encoding PVL as a major cause of community onset staphylococcal infections in Argentinean children. PLoS One (2012) 1.01
Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid. Pharmacotherapy (2014) 1.00
Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest (2010) 0.98
Trends in invasive infection with methicillin-resistant Staphylococcus aureus, Connecticut, USA, 2001-2010. Emerg Infect Dis (2012) 0.97
Bacterial Hypoxic Responses Revealed as Critical Determinants of the Host-Pathogen Outcome by TnSeq Analysis of Staphylococcus aureus Invasive Infection. PLoS Pathog (2015) 0.95
Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens. PLoS One (2012) 0.95
Trends in adverse reactions to trimethoprim-sulfamethoxazole. Pediatrics (2012) 0.93
Trends in resource utilization for hospitalized children with skin and soft tissue infections. Pediatrics (2013) 0.90
Management of acute hematogenous osteomyelitis in children. Expert Rev Anti Infect Ther (2010) 0.90
Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009. J Bone Joint Surg Am (2015) 0.87
Impact of colonization pressure and strain type on methicillin-resistant Staphylococcus aureus transmission in children. Clin Infect Dis (2013) 0.87
No evidence of vancomycin minimal inhibitory concentration creep or heteroresistance identified in pediatric Staphylococcus aureus blood isolates. Pediatr Infect Dis J (2014) 0.86
Trends in hospitalizations with antibiotic-resistant infections: U.S., 1997-2006. Public Health Rep (2011) 0.85
Ceftobiprole efficacy in vitro against Panton-Valentine leukocidin production and in vivo against community-associated methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits. Antimicrob Agents Chemother (2012) 0.85
Prevention of Recurrent Staphylococcal Skin Infections. Infect Dis Clin North Am (2015) 0.84
Population-based study of the increased incidence of skin and soft tissue infections and associated antimicrobial use. Antimicrob Agents Chemother (2012) 0.83
Pathogenic role of macrophages in intradermal infection of methicillin-resistant Staphylococcus aureus in thermally injured mice. Infect Immun (2010) 0.83
Staphylococcal infections in children, California, USA, 1985-2009. Emerg Infect Dis (2013) 0.82
Comparative effectiveness of linezolid and vancomycin among a national cohort of patients infected with methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 0.80
Outcomes of laparoscopic versus open fundoplication in children's hospitals: 2005-2008. Pediatrics (2011) 0.80
Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children. Infect Dis Ther (2013) 0.80
Trends in Infectious Disease Hospitalizations in US Children, 2000 to 2012. Pediatr Infect Dis J (2016) 0.78
Population-Based Pharmacokinetic Modeling of Vancomycin in Children with Renal Insufficiency. J Pharmacol Clin Toxicol (2014) 0.78
Effects of aggregate and individual antibiotic exposure on vancomycin MICs for Staphylococcus aureus isolates recovered from pediatric patients. J Clin Microbiol (2013) 0.76
Acute MRSA sinusitis with intracranial extension and marginal vancomycin susceptibility. Case Rep Pediatr (2013) 0.75
Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis. Antimicrob Agents Chemother (2016) 0.75
Rifampin use and safety in hospitalized infants. Am J Perinatol (2015) 0.75
The Mechanism Underlying the Antibacterial Activity of Shikonin against Methicillin-Resistant Staphylococcus aureus. Evid Based Complement Alternat Med (2015) 0.75
Indole trimers with antibacterial activity against Gram-positive organisms produced using combinatorial biocatalysis. AMB Express (2015) 0.75
Association of neighborhood-level factors with hospitalization for community-associated methicillin-resistant Staphylococcus aureus, New York City, 2006: a multilevel observational study. BMC Infect Dis (2013) 0.75
Incidence of methicillin-resistant Staphylococcus aureus infection in a children's hospital in the Washington metropolitan area of the United States, 2003 - 2010. Emerg Microbes Infect (2013) 0.75
Outcomes in pediatric surgery by hospital volume: a population-based comparison. Pediatr Surg Int (2013) 0.75
Antibacterial photosensitization through activation of coproporphyrinogen oxidase. Proc Natl Acad Sci U S A (2017) 0.75
Dosing antibiotics in neonates: review of the pharmacokinetic data. Future Microbiol (2017) 0.75
Community-associated methicillin-resistant Staphylococcus aureus infection: Literature review and clinical update. Can Fam Physician (2017) 0.75
Staphylococcus aureus infections. N Engl J Med (1998) 36.39
Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA (2007) 26.98
Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med (2006) 18.83
Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med (2005) 12.75
Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis (2007) 6.75
Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis (2008) 4.92
Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2008) 4.48
Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980-1997. Pediatrics (2000) 4.29
Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis (2005) 3.91
The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect (2007) 3.24
Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med (2007) 3.16
Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis (2007) 3.12
Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis (2005) 3.09
Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J (2002) 2.47
A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis (2008) 2.35
Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive staphylococcus aureus colonization in children seen in a practice-based research network. Pediatrics (2008) 1.85
Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2008) 1.82
National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. Am J Infect Control (2007) 1.79
Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J (2007) 1.65
A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J (2008) 1.50
Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect (2006) 1.36
Management of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis (2008) 1.26
Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients. Emerg Infect Dis (2005) 1.13
Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients. Infect Dis Clin North Am (2005) 0.98
Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis (2005) 13.97
Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 3.13
Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr (2007) 2.75
Administrative data fail to accurately identify cases of healthcare-associated infection. Infect Control Hosp Epidemiol (2006) 2.39
A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.32
Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics (2008) 2.31
Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.30
Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.22
Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics (2012) 2.04
Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis (2006) 2.02
Treatment with oseltamivir in children hospitalized with community-acquired, laboratory-confirmed influenza: review of five seasons and evaluation of an electronic reminder. J Hosp Med (2009) 1.95
Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet (2013) 1.94
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections. Arch Intern Med (2009) 1.86
Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infect Control Hosp Epidemiol (2009) 1.85
Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.84
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med (2005) 1.82
Beyond cat scratch disease: widening spectrum of Bartonella henselae infection. Pediatrics (2008) 1.80
Clostridium difficile Infection in children. JAMA Pediatr (2013) 1.76
Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA (2005) 1.67
Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.66
Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children. Clin Infect Dis (2013) 1.64
Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study. Pediatr Infect Dis J (2011) 1.59
A national outbreak of Ralstonia mannitolilytica associated with use of a contaminated oxygen-delivery device among pediatric patients. Pediatrics (2007) 1.55
Identifying targets for antimicrobial stewardship in children's hospitals. Infect Control Hosp Epidemiol (2013) 1.54
Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics (2007) 1.54
Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics (2008) 1.49
Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J (2004) 1.45
Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Clin Infect Dis (2005) 1.39
Hyperglycemia at the Time of Acquiring Central Catheter-Associated Bloodstream Infections Is Associated With Mortality in Critically Ill Children. Pediatr Crit Care Med (2015) 1.39
Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol (2009) 1.38
Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis (2010) 1.36
Variability in antibiotic use at children's hospitals. Pediatrics (2010) 1.34
Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics (2005) 1.33
Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses. J Immunol (2002) 1.28
Immune dysregulation in severe influenza. J Leukoc Biol (2009) 1.27
Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol (2014) 1.22
Clinical and molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus infections among children with risk factors for health care-associated infection: 2001-2003. Pediatr Infect Dis J (2006) 1.21
Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J (2008) 1.20
Epidemiology of cryptococcal infection in hospitalized children. Pediatr Infect Dis J (2010) 1.19
Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics (2006) 1.17
Direct medical cost of influenza-related hospitalizations in children. Pediatrics (2006) 1.17
Pediatric antifungal utilization: new drugs, new trends. Pediatr Infect Dis J (2008) 1.15
Risk factors for renal failure in pediatric patients with acute myeloid leukemia: a retrospective cohort study. Pediatr Blood Cancer (2010) 1.15
Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008. Pediatrics (2010) 1.13
ICD-9 codes for identifying influenza hospitalizations in children. Emerg Infect Dis (2006) 1.12
Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use. Int J Antimicrob Agents (2006) 1.12
Risk factors for mortality in children with candidemia. Pediatr Infect Dis J (2005) 1.11
Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates. Pediatr Infect Dis J (2012) 1.09
Risk factors and outcomes associated with severe clostridium difficile infection in children. Pediatr Infect Dis J (2012) 1.05
Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus. Pediatrics (2009) 1.04
Employee designation and health care worker support of an influenza vaccine mandate at a large pediatric tertiary care hospital. Vaccine (2011) 1.03
Cefepime and mortality in pediatric acute myelogenous leukemia: a retrospective cohort study. Pediatr Infect Dis J (2009) 1.02
Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States. Pediatr Crit Care Med (2014) 1.02
Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers. Am J Infect Control (2010) 1.02
Postoperative mediastinitis in children: epidemiology, microbiology and risk factors for Gram-negative pathogens. Pediatr Infect Dis J (2005) 1.01
Racial differences in antibiotic prescribing by primary care pediatricians. Pediatrics (2013) 0.99
Catheter dwell time and CLABSIs in neonates with PICCs: a multicenter cohort study. Pediatrics (2013) 0.98
Impact of Infectious Diseases Society of America/Pediatric Infectious Diseases Society guidelines on treatment of community-acquired pneumonia in hospitalized children. Clin Infect Dis (2014) 0.96
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data. Pediatr Blood Cancer (2011) 0.96
Botulinum toxin as a novel treatment for self-mutilation in Lesch-Nyhan syndrome. Dev Med Child Neurol (2005) 0.96
Communicating science to the public: MMR vaccine and autism. Vaccine (2003) 0.93
Posaconazole: when and how? The clinician's view. Mycoses (2011) 0.93
Addisonian pigmentation of the oral mucosa. Cutis (2005) 0.93
Risk Factors and Outcomes for Vancomycin-Resistant Enterococcus Bloodstream Infection in Children. Infect Control Hosp Epidemiol (2010) 0.92
Doctors choosing not to be vaccinated is choosing to do harm. BMJ (2011) 0.90
Bloodstream infection caused by Stenotrophomonas maltophilia in children. Pediatr Infect Dis J (2007) 0.88
Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients. Infect Control Hosp Epidemiol (2012) 0.88
Community acquired influenza requiring hospitalization: vaccine status is unrelated to morbidity in children with cancer. Pediatr Blood Cancer (2010) 0.87
Smallpox vaccination: a national survey of emergency health care providers. Acad Emerg Med (2003) 0.87
The categorization of prior antibiotic use: impact on the identification of risk factors for drug resistance in case control studies. Am J Infect Control (2007) 0.86
Hospitalizations for coccidioidomycosis at forty-one children's hospitals in the United States. Pediatr Infect Dis J (2010) 0.86
Beyond the bundle: a survey of central line-associated bloodstream infection prevention practices used in US and Canadian pediatric hospitals. Infect Control Hosp Epidemiol (2013) 0.86
Pediatric antimicrobial susceptibility trends across the United States. Infect Control Hosp Epidemiol (2013) 0.85
The clinical and molecular epidemiology of community- and healthcare-acquired rotavirus gastroenteritis. Pediatr Infect Dis J (2008) 0.85
Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol (2014) 0.84
Infection control, hospital epidemiology, and patient safety. Infect Dis Clin North Am (2005) 0.84
Assessing hand hygiene resources and practices at a large african teaching hospital. Infect Control Hosp Epidemiol (2010) 0.84
Bloodstream Infections in Hospitalized Children: Epidemiology and Antimicrobial Susceptibilities. Pediatr Infect Dis J (2016) 0.83
Trends in zygomycosis in children. Mycoses (2011) 0.83
Preevent vaccination against smallpox: a survey of pediatric emergency health care providers. Pediatr Infect Dis J (2004) 0.83
Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Pediatr Infect Dis J (2007) 0.83
Risk factors for catheter-associated bloodstream infections in a Pediatric Cardiac Intensive Care Unit. Pediatr Infect Dis J (2010) 0.83
Influence of bedding type on mucosal immune responses. Comp Med (2002) 0.82
Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections. Am J Infect Control (2010) 0.82
Device-related infections in children. Pediatr Clin North Am (2005) 0.82
Early differentiation of Lyme from enteroviral meningitis. Pediatr Infect Dis J (2005) 0.82